August 11, 2025 - 00:32

In a significant move that underscores the strengthening of ties between Taiwan and the United States, a major technology manufacturer has announced plans to invest $1 billion in the U.S. market. This investment is expected to bolster the production capabilities and supply chain resilience of the company, which has long been a key player in the global electronics sector.
The funds will be directed towards expanding existing facilities and potentially establishing new ones, aimed at enhancing the production of advanced technologies. This initiative is not only anticipated to create thousands of jobs in the U.S. but also signifies a strategic pivot towards localizing supply chains in response to global economic challenges.
By investing in the U.S., the company aims to cater to the growing demand for high-tech products while also ensuring greater operational efficiency. This move is seen as a testament to the company's commitment to innovation and its role in the global technology landscape, further integrating Taiwan's manufacturing prowess with the U.S. economy.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...